The Telepsychiatry Advantage
The Telepsychiatry Advantage is a podcast for clinicians who want a clear, practical understanding of how telepsychiatry actually works. As more care moves online, the show breaks down the real considerations behind it—who it works for, where it doesn’t, how to handle risk, what regulations matter, and how to deliver care effectively through a screen. Each episode focuses on what you need to know to make better decisions and avoid common mistakes in a rapidly changing environment.
Your host is Dr. Edward Kaftarian, the founder of Orbit Health, the longest-running telepsychiatry company in the world. He received his psychiatry training at the renowned Johns Hopkins University and holds board certifications in Psychiatry, Forensic Psychiatry, and Addiction Medicine.
The Telepsychiatry Advantage
Ryan Haight Act: What Happens When Telemedicine Flexibilities End? (Part 2)
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
The entire telemedicine industry has one date on its mind: December 31, 2026. That’s when the current telemedicine prescribing flexibilities are set to expire, creating what many in the field now call the “telemedicine cliff.”
These flexibilities were created during the pandemic and allowed many clinicians to prescribe controlled substances remotely without an initial in-person visit. If they expire without a clear replacement, patients could lose access to medications overnight.
The telepsychiatry industry can and will change depending on what the government decides to do next. In part two of our Ryan Haight Act series, Dr. Edward Kaftarian explains what’s going on, tries to read the “tea leaves” the DEA is leaving, and walks through what psychiatrists should be thinking about before the deadline arrives.
For more information about Orbit Health, visit us at:
https://www.orbithealth.com/